BlackRock Fund Advisors’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

BlackRock Fund Advisors’s Portfolio TRIV Stock Details TRIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-24,780	Closed	-$165K	–	4376
2015 Q4	$165K	Sell	24,780 -2,535	-9%	-$16.8K	﹤0.01%	3607
2015 Q3	$137K	Buy	27,315 +4,963	+22%	+$26.7K	﹤0.01%	3617
2015 Q2	$120K	Sell	22,352 -181,497	-89%	-$1.29M	﹤0.01%	3702
2015 Q1	$2.14M	Sell	203,849 -164	-0.1%	-$1.69K	﹤0.01%	3115
2014 Q4	$2.56M	Buy	204,013 +28,460	+16%	+$388K	﹤0.01%	3112
2014 Q3	$2.54M	Buy	+175,553	New	+$2.55M	﹤0.01%	3078

BlackRock Fund Advisors's TRIV Position: Q1 2016 in Review

BlackRock Fund Advisors sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q1 2016, closing a stake of 24,780 shares — an estimated $165K sold.

BlackRock Fund Advisors first reported a position in TRIV in Q3 2014 and held it in 6 quarters. The position peaked at $2.56M in Q4 2014. 0 funds tracked by Wall St. Rank hold TRIV as of Q1 2016.

BlackRock Fund Advisors reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q1 2016 after selling out during the quarter.
BlackRock Fund Advisors sold 24,780 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q1 2016, an estimated $165K.
BlackRock Fund Advisors first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q3 2014 and held it in 6 quarters.
BlackRock Fund Advisors's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $2.56M in Q4 2014.
0 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q1 2016.

Based on BlackRock Fund Advisors's 13F filing for Q1 2016, filed 10 May 2016.